Statistical methods for Mendelian models with multiple genes and cancers
Jane W. Liang, Gregory E. Idos, Christine Hong, Stephen B. Gruber,, Giovanni Parmigiani, Danielle Braun

TL;DR
This paper introduces PanelPRO, a flexible Mendelian risk prediction framework capable of modeling multiple genes and cancers simultaneously, addressing limitations of existing models and validated with simulations and clinical data.
Contribution
Developed PanelPRO, the largest Mendelian model to date, capable of incorporating numerous genes and cancers, overcoming computational challenges of complex genetic risk modeling.
Findings
Validated model performance with simulations and clinical data
Demonstrated reverse-compatibility with existing models
Provided an open-source R package for research use
Abstract
Risk evaluation to identify individuals who are at greater risk of cancer as a result of heritable pathogenic variants is a valuable component of individualized clinical management. Using principles of Mendelian genetics, Bayesian probability theory, and variant-specific knowledge, Mendelian models derive the probability of carrying a pathogenic variant and developing cancer in the future, based on family history. Existing Mendelian models are widely employed, but are generally limited to specific genes and syndromes. However, the upsurge of multi-gene panel germline testing has spurred the discovery of many new gene-cancer associations that are not presently accounted for in these models. We have developed PanelPRO, a flexible, efficient Mendelian risk prediction framework that can incorporate an arbitrary number of genes and cancers, overcoming the computational challenges that arise…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGenetic Associations and Epidemiology · BRCA gene mutations in cancer · Genomics and Rare Diseases
